Gossamer Bio, Inc. GOSS
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 9.24M | 16.96M | 13.80M | 13.29M | 11.49M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.24M | 16.96M | 13.80M | 13.29M | 11.49M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 9.24M | 16.96M | 13.80M | 13.29M | 11.49M |
| SG&A Expenses | 8.90M | 18.75M | 10.90M | 9.39M | 8.68M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 35.31M | 61.82M | 59.84M | 54.93M | 50.25M |
| Operating Income | -26.07M | -44.87M | -46.04M | -41.64M | -38.77M |
| Income Before Tax | 16.90M | -46.66M | -47.33M | -48.22M | -38.27M |
| Income Tax Expenses | -- | -- | -88.00K | -- | -- |
| Earnings from Continuing Operations | 16.90M | -46.66M | -47.24M | -48.22M | -38.27M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 16.90M | -46.66M | -47.24M | -48.22M | -38.27M |
| EBIT | -26.07M | -44.87M | -46.04M | -41.64M | -38.77M |
| EBITDA | -26.07M | -44.86M | -46.03M | -41.63M | -38.76M |
| EPS Basic | 4.22 | -15.94 | -16.68 | -16.92 | -13.47 |
| Normalized Basic EPS | -4.21 | -9.97 | -11.43 | -8.94 | -8.42 |
| EPS Diluted | -6.12 | -15.94 | -16.68 | -16.92 | -13.60 |
| Normalized Diluted EPS | -4.10 | -9.97 | -11.43 | -8.94 | -8.42 |
| Average Basic Shares Outstanding | 4.00M | 2.93M | 2.83M | 2.85M | 2.84M |
| Average Diluted Shares Outstanding | 4.11M | 2.93M | 2.83M | 2.85M | 2.84M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |